SOP Guide for Pharma

BA-BE Studies: SOP for First-Aid Management of Mild Reactions – V 2.0

BA-BE Studies: SOP for First-Aid Management of Mild Reactions – V 2.0

Standard Operating Procedure for First-Aid Management of Mild Reactions in BA/BE Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/067/2025
Supersedes SOP/BA-BE/067/2022
Page No. Page 1 of 9
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To establish a clear and systematic approach for recognizing, providing first-aid, and documenting mild adverse reactions in volunteers participating in Bioavailability/Bioequivalence (BA/BE) studies.

2. Scope

This SOP is applicable to all clinical staff responsible for safety monitoring, emergency readiness, and initial medical intervention for mild events such as nausea, headache, giddiness, or injection-site irritation in BA/BE clinical studies.

3. Responsibilities

  • Nursing Staff: Identify symptoms,
provide immediate care, and escalate when necessary.
  • Clinical Research Coordinator (CRC): Ensure availability of first-aid supplies and document events in the safety log.
  • Investigator/Sub-Investigator: Review and approve the first-aid provided and determine follow-up care.
  • 4. Accountability

    The Principal Investigator is accountable for ensuring that all mild adverse events are promptly addressed, properly documented, and that staff are trained in basic first-aid procedures.

    5. Procedure

    5.1 Identification of Mild Reactions

    1. Train staff to identify symptoms typically classified as mild reactions:
      • Nausea or vomiting (non-severe)
      • Headache, dizziness
      • Mild rash or itching
      • Transient hypotension not requiring medical intervention

    5.2 Immediate First-Aid Management

    1. Place the subject in a comfortable position and ensure proper ventilation.
    2. Provide fluids (if allowed by protocol) for dehydration or dizziness.
    3. Apply cold compress for headache or rashes.
    4. Use first-aid kit items such as:
      • Antiemetic tablets for nausea
      • Antihistamines for minor allergic reactions (under PI supervision)
      • ORS solution for mild dehydration

    5.3 Documentation of Event

    1. Record the incident in Annexure-1: Mild Reaction First-Aid Log, including:
      • Subject ID
      • Time of symptom onset
      • Description and severity
      • First-aid provided
      • Outcome and recovery time
    2. Inform the Investigator or Sub-Investigator for review and signature.

    5.4 Escalation Criteria

    1. If symptoms worsen or do not resolve with first-aid, initiate medical evaluation.
    2. Convert to Adverse Event (AE) or Serious Adverse Event (SAE) reporting pathway as needed.

    5.5 First-Aid Supplies Checklist

    1. Maintain a stocked and easily accessible first-aid kit in the clinical area.
    2. Checklist to include:
      • Cotton, antiseptic, gauze, gloves
      • Paracetamol, antiemetics, antihistamines
      • ORS sachets, thermometer, glucose powder
    3. Document monthly inspections of first-aid kit in Annexure-2: First-Aid Kit Maintenance Log.

    6. Abbreviations

    • BA: Bioavailability
    • BE: Bioequivalence
    • PI: Principal Investigator
    • AE: Adverse Event
    • SAE: Serious Adverse Event

    7. Documents

    1. Mild Reaction First-Aid Log – Annexure-1
    2. First-Aid Kit Maintenance Log – Annexure-2

    8. References

    • ICH E6(R2) – Good Clinical Practice
    • CDSCO Guidelines for Clinical Safety
    • WHO First-Aid Training Manual

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Mild Reaction First-Aid Log

    Subject ID Symptom Onset Time First-Aid Given Outcome Reviewed By
    VOL-067 Headache 08:30 Cold compress Resolved Dr. Sunita Reddy

    Annexure-2: First-Aid Kit Maintenance Log

    Date Inspected By Items Replenished Remarks
    10/04/2025 Ravi Nair ORS, gloves Stocked and verified

    Revision History:

    Revision Date Revision No. Details Reason Approved By
    12/01/2022 1.0 Initial version BA/BE implementation QA Head
    17/04/2025 2.0 Included escalation pathway and annexure logs Audit requirement QA Head
    Exit mobile version